Crispr Therapeutics shares tumble after significant earnings miss
William J. Lansing, President and CEO of Fair Isaac Corp (NYSE:FICO), recently executed a series of stock transactions involving the company’s common stock. According to a Form 4 filing with the Securities and Exchange Commission, Lansing sold shares worth approximately $3.25 million on March 11, 2025. The sales occurred at prices ranging from $1,676.81 to $1,715.34 per share. The transaction comes as FICO maintains strong financial fundamentals, with impressive gross profit margins of 80% and revenue growth of 14.5% over the last twelve months.
In addition to the sales, Lansing also acquired 6,011 shares through the exercise of non-qualified stock options. These shares were acquired at an exercise price of $185.05 each, totaling approximately $1.11 million. Following these transactions, Lansing holds direct ownership of 46,697 shares in Fair Isaac Corp, representing a stake in the company now valued at $42.8 billion by market capitalization.
The transactions are part of an ongoing trading plan, as indicated in the filing. Investors often scrutinize such insider transactions for signals about a company’s future performance or the executive’s confidence in the business. According to InvestingPro analysis, FICO currently trades above its Fair Value, with multiple valuation metrics suggesting premium pricing. For deeper insights into FICO’s valuation and comprehensive insider trading analysis, investors can access the detailed Pro Research Report, available exclusively to InvestingPro subscribers.
In other recent news, Fair Isaac Corporation (FICO) reported its financial results for the first quarter of fiscal year 2024, revealing earnings per share (EPS) of $5.79, which fell short of the forecasted $6.08. The company’s revenue also missed expectations, coming in at $440 million against a forecast of $451.42 million. Despite these setbacks, FICO is maintaining its fiscal 2025 guidance, expecting consolidated revenues of $1.98 billion and an adjusted EPS of $28.58. Meanwhile, FICO has expanded its intellectual property portfolio with several new patents in AI and machine learning, covering technologies such as fraud detection and cybersecurity.
Additionally, RBC Capital Markets upgraded Fair Isaac’s stock rating from Sector Perform to Outperform, raising the price target to $2,170 from $2,040, citing the company’s strong market position and financial strategies. However, JPMorgan analysts cut their price target to $1,900 from $2,150, maintaining a Neutral rating after the company’s earnings report showed slower-than-expected revenue growth in the Scores segment. In a strategic move, FICO partnered with TransUnion (NYSE:TRU) Kenya to introduce new credit risk management solutions in Kenya, aiming to enhance financial inclusion with products like CreditVision Variables and a Kenya-specific FICO Score. These developments underscore FICO’s ongoing efforts to innovate and expand its reach in the global market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.